MoonLake Immunotherapeutics • MLTX

Capital at risk.

About MoonLake Immunotherapeutics
Ticker
info
MLTX
Trading on
info
NASDAQ
ISIN
info
KY61559X1045
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Jorge Santos da Silva Ph.D.
Headquarters
info
Dorfstrasse 29, Zug, undefined, Switzerland, 6300
Employees
info
100
Website
info
moonlaketx.com
MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Metrics
BasicAdvanced
Market cap
info
$905M
P/E ratio
info
-
EPS
info
-$3.33
Dividend Yield
info
0.00%
Beta
info
1.24
Forward P/E ratio
info
0
EBIDTA
info
$-227M
Ex dividend date
info
-
Price & volume
Market cap
info
$905M
Average daily volume
info
2.6M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
2.88
Earnings
EPS
info
-$3.33
EPS estimate (current quarter)
info
-$0.92
EPS estimate (next quarter)
info
-$0.92
EBITDA
info
$-227M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.24
52-week High
info
$62.75
52-week Low
info
$5.95
50-day moving average
info
$26.13
200-day moving average
info
$39.91
Short ratio
info
0.66
Short %
info
17.21%
Management effectiveness
ROE (TTM)
info
-54.33%
ROA (TTM)
info
-30.72%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
70.8M
Float
info
36.1M
Insiders %
info
9.82%
Institutions %
info
73.32%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 16 analysts.

Average price target

info
$14.79
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.72
-$0.59
-21.46%
Q4 • 24Missed
-$0.63
-$0.74
14.34%
Q1 • 25Beat
-$0.87
-$0.72
-20.83%
Q2 • 25Missed
-$1.10
-$0.88
-25.17%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-55.2M
-∞%
Q2 • 25
$0M
$-69.7M
-∞%
Q3 • 25
NaN%
26.27%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$460M
$102M
22.20%
Q2 • 25
$414M
$123M
29.72%
Q3 • 25
-9.95%
20.55%
33.86%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-54.5M
$88.3M
$0M
$-54.5M
Q2 • 25
$-44.5M
$88.4M
$0.5M
$-44.5M
Q3 • 25
-18.31%
0.17%
∞%
-18.31%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a MoonLake Immunotherapeutics share?
Collapse

MoonLake Immunotherapeutics shares are currently traded for undefined per share.

How many shares does MoonLake Immunotherapeutics have?
Collapse

MoonLake Immunotherapeutics currently has 70.8M shares.

Does MoonLake Immunotherapeutics pay dividends?
Collapse

No, MoonLake Immunotherapeutics doesn't pay dividends.

What is MoonLake Immunotherapeutics 52 week high?
Collapse

MoonLake Immunotherapeutics 52 week high is $62.75.

What is MoonLake Immunotherapeutics 52 week low?
Collapse

MoonLake Immunotherapeutics 52 week low is $5.95.

What is the 200-day moving average of MoonLake Immunotherapeutics?
Collapse

MoonLake Immunotherapeutics 200-day moving average is $39.91.

Who is MoonLake Immunotherapeutics CEO?
Collapse

The CEO of MoonLake Immunotherapeutics is Dr. Jorge Santos da Silva Ph.D..

How many employees MoonLake Immunotherapeutics has?
Collapse

MoonLake Immunotherapeutics has 100 employees.

What is the market cap of MoonLake Immunotherapeutics?
Collapse

The market cap of MoonLake Immunotherapeutics is $905M.

What is the P/E of MoonLake Immunotherapeutics?
Collapse

The current P/E of MoonLake Immunotherapeutics is null.

What is the EPS of MoonLake Immunotherapeutics?
Collapse

The EPS of MoonLake Immunotherapeutics is -$3.33.

What is the PEG Ratio of MoonLake Immunotherapeutics?
Collapse

The PEG Ratio of MoonLake Immunotherapeutics is null.

What do analysts say about MoonLake Immunotherapeutics?
Collapse

According to the analysts MoonLake Immunotherapeutics is considered a buy.